Subclinical Thyroid Disease in the Elderly
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The development of sensitive assays for thyrotropin (TSH) has led to the discovery that many older patients have abnormal TSH levels without other alterations in serum thyroid hormone levels, conditions termed subclinical hypothyroidism (isolated elevation of TSH levels) and subclinical hyperthyroidism (isolated suppression of TSH levels). Subclinical hypothyroidism occurs in 5% to 10% of elderly subjects, and is especially prevalent in elderly women. Subclinical hyperthyroidism is less common, affecting less than 2% of the elderly population. The causes of subclinical thyroid disease in the elderly are similar to those of thyroid disease in the general population, although medications and iodine-containing compounds may play an increased role. Potential risks of subclinical hypothyroidism in the elderly include progression to overt hypothyroidism, cardiovascular effects, hyperlipidemia, and neurological and neuropsychiatric effects. Potential risks of subclinical hyperthyroidism in the elderly include progression to overt hyperthyroidism, cardiovascular effects (especially atrial fibrillation), and osteoporosis. Decisions to treat elderly subjects with subclinical thyroid disease should be based on a careful assessment of these risks in the individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 3×
“Data on the development of overt hyperthyroidism in elderly subjects with initial suppression of TSH levels are 7) (21,32,36,37).”
L-Thyroxine Therapy in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Trial
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & RIDGWAY, E. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-18 · Cited by 423 · cited 2×
“Despite the appellation of "subclinical" hypothyroidism, patients with isolated TSH elevations may have symptoms consistent with hypothyroidism (25,46,49).”
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398 · cited 1×
“As summarized by two recent meta-analyses, some (but not all) of these studies show lower bone mineral density at hip, spine, and/or radius in postmenopausal women, and occasionally in pre-menopausal women, receiving thyroid hormone, compared to nontreated control subjects (84,85).”
Faber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Complex alteration of thyroid function in healthy centenarians.
Mariotti, S., Barbesino, G., Caturegli, P., Bartalena, L., Sansoni, P., Fagnoni, F., Monti, D., Fagiolo, U., Franceschi, C., & Pinchera, A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077303 · Cited by 234
HYPERTHYROIDISM IN PATIENTS OVER THE AGE OF 60 YEARS: CLINICAL FEATURES IN 85 PATIENTS
DAVIS, P. J., & DAVIS, F. B. (1974) · Medicine · doi:10.1097/00005792-197405000-00001 · Cited by 206
Accelerated Bone Loss in Hypothyroid Patients Overtreated with L-Thyroxine
Stall, G. M., Harris, S., Sokoll, L. J., & Dawson-Hughes, B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-265 · Cited by 203
Földes, J., Tarján, G., Szathmari, M., Varga, F., Krasznai, I., & Horvath, C. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02403.x · Cited by 170 · cited 3×
“Foldes et al. (83) compared 37 women with solitary thyroid nodules and subclinical hyperthyroidism to 32 euthyroid women with thyroid nodules, and found decreases in bone mineral density at the femoral neck and midshaft radius in the postmenopausal women (but not in pre-menopausal women) with…”
InfluentialLevothyroxine Replacement Dose for Primary Hypothyroidism Decreases with Age
ROSENBAUM, R. L., & BARZEL, U. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-53 · Cited by 163 · cited 1×
“The target dose of levothyroxine is lower than the typical full replacement dose using in young subjects, because patients with subclinical hypothyroidism may not require full replacement doses, and because the elderly have decreased metabolism of thyroxine (91,92).”
Sawin, C. T., Herman, T., Molitch, M. E., London, M. H., & Kramer, S. M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91192-0 · Cited by 139
Cited by
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
“The typical findings of hypothyroidism are less common in the elderly and, when present, are often attributed to chronic illnesses, drugs, depression, or age (119, 120).”
BackgroundAndersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Effects of Subclinical Thyroid Dysfunction on the Heart
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00011 · Cited by 445
Effects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M. S., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 392
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
“The adverse effects of SHyper are closely related to the patient’s age (70).”
The Value of Ultrasonography in Predicting Autoimmune Thyroid Disease
Pedersen, O. M., Aardal, N. P., Larssen, T. B., Varhaug, J. E., Myking, O., & Vik-Mo, H. (2000) · Thyroid · doi:10.1089/thy.2000.10.251 · Cited by 272
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0854 · Cited by 118
Peeters, R. P. (2008) · Hormones · doi:10.14310/horm.2002.1111035 · Cited by 98
Papi, G., Pearce, E. N., Braverman, L. E., Betterle, C., & Roti, E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.004 · Cited by 39
Standardization activities in the field of thyroid function tests: a status report
Thienpont, L. M., Van Uytfanghe, K., & Van Houcke, S. (2010) · cclm · doi:10.1515/cclm.2010.321 · Cited by 29
Metadata
- Authors
- SAMUELS, M. H.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1998-09
- Volume
- 8
- Issue
- 9
- Pages
- 803-813
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1981012541
- Cited by
- 129
- References
- 13
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.